Bilateral sphenopalatine ganglion block reduces blood pressure in patients with essential hypertension

I have been utilizing bilateral SPG Blocks to treat TMJ pain, MPD, Anxiety, Chronic Pain, Tension Headaches, Migraine Headaches, Dluster Headaches and Fibromyalgia.  SPG Blocks can be used to reverse central sensitization and can serve as a replacement for a host of medications utilized for headaches, anxiety, depression, neuralgias not only saving reources but also reducing harmful side effects.

This brand new study shows the effectiveness of bi;ateral SPG Blocks in treating Essential Hypertension.

The study concludes that “SPG block is a promising, minimally invasive option of BP decrease in hypertensives, probably through SNS modulation. ”  Additionally, due to its anesthetic effect, SPG block might act as a method of selection for those hypertensive patients with an activated SNS before any other invasive antihypertensive procedure.

Self Administration of Sphenopalatine Ganglion Blocks may be the best route to address essential hypertension in the future.  It is extremely inexpensive and very patient friendly, ie no time out of their busy schedules for doctor visits.

The generalized feelings of well being and reduced stress probably have multiple other health benefits as well.  There are several testimonials about my patient’s experiences with SPG Blocks at:  https://www.reddit.com/r/SPGBlocks/

I have taught the SPG Block procedures to ICCMO.org members at meetings in Scottsdale, Seattle and Buenos Aires.  These doctors are the experts in Neuromuscular Dentistry.  Neuromuscular dentists utilize the Myomonitor to relax trigeminally innervated muscle.  This same device also acts as a Sphenopalatine Ganglion stimulator and it has a remarkable 50 year exemplary safety record.  The stimulation of the SPG may be why neuromuscular dentistry is exceptional in treating TMJ disorders, orofacial pain, MPD, as well as other chronic head and neck pain and dysfunction.

It should be noted that neuromuscular dentistry utilizes the Myomonitor that has a 50 year exceptional safety record as a SPG stimulator as well as neuromuscular stim or the 5th and 7th cranial nerves.

Int J Cardiol. 2018 Jan 1;250:233-239. doi: 10.1016/j.ijcard.2017.10.042. Epub 2017 Oct 16.

Bilateral sphenopalatine ganglion block reduces blood pressure in never treated patients with essential hypertension. A randomized controlled single-blinded study.

Abstract

BACKGROUND:

Sympathetic fibers connect sphenopalatine ganglion (SPG) with the central nervous system. We aimed to study the effect of SPG block in blood pressure (BP) in never treated patients with stage I-II essential hypertension.

METHODS:

We performed bilateral SPG block with lidocaine 2% in 33 hypertensive patients (mean age 48±12years, 24 men) and a sham operation with water for injection in 11 patients who served as the control group (mean age 51±12years, 8 men). All patients have been subjected to 24h ambulatory blood pressure monitoring prior and a month after the SBG block in order to estimate any differences in blood pressure parameters. We defined as responders to SBG block those patients with a 24h SBP decrease ≥5mmHg.

RESULTS:

We found that 24h and daytime DBP (p=0.02) as well as daytime DBP load (p=0.03) were decreased in the study group a month after SPG block. In addition, a significant response was noted in 12/33 responders (36%) regarding: a. SBP and DBP during overall 24h and daytime (p<0.001) and night-time periods, b. pre-awake and early morning SBP and c. SBP (daytime and night-time) and DBP (daytime) load. No differences regarding BP were found in the sham operation group.

CONCLUSIONS:

SPG block is a promising, minimally invasive option of BP decrease in hypertensives, probably through SNS modulation. Additionally, due to its anesthetic effect, SPG block might act as a method of selection for those hypertensive patients with an activated SNS before any other invasive antihypertensive procedure.

KEYWORDS:

24h blood pressure measurement (24h ABPM); Arterial hypertension; Neural blockSphenopalatine ganglion

PMID:
29074041
DOI:
10.1016/j.ijcard.2017.10.042
Ira L Shapira DDS, D,ABDSM, D,AAPM, FICCMO
Past Chair, Alliance of TMD Organizations
Diplomat,  Academy of Integrative Pain Management
Diplomat, American Board of Dental Sleep Medicine
Regent & Fellow, International College of CranioMandibular Orthopedics
Board Eligible, American Academy of CranioFacial Pain
Dental Section Editor, Sleep & Health Journal
Member, American Equilibration Society

Member, Academy of Applied Myofunctional Sciences

Member, Academy of Cosmetic Dentistry
www.ThinkBetterLife.com
www.DelanyDentalCare.com

www.NorthShoreSleepDentist.com
www.IHateCPAP.com
www.iHateHeadaches.org

www.SleepandHealth.com
www.SphenopalatineGanglionBlocks.com
https://www.youtube.com/channel/UCk9Bfz6pklC7_UluWFHzLrg

Leave a Reply

Your email address will not be published. Required fields are marked *